Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Alignment Healthcare, Inc. Director's Dealing 2021

Oct 22, 2021

31270_dirs_2021-10-22_a4463df7-db21-4997-bc55-18669eaf91a5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Alignment Healthcare, Inc. (ALHC)
CIK: 0001832466
Period of Report: 2021-10-20

Reporting Person: Freeman Robert Thomas (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-10-20 Common Stock S 23000 $19.381 Disposed 817218 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 283916 Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. The reported price in column 4 is a weighted average price. The Reporting Person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in footnote (2) to this Form 4.

F2: The shares were sold in multiple transactions at prices ranging from $19.26 to $19.51 per share.

F3: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary.